BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36449454)

  • 21. Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis.
    Kimanga DO; Makory VNB; Hassan AS; Ngari F; Ndisha MM; Muthoka KJ; Odero L; Omoro GO; Aoko A; Ng'ang'a L
    PLoS One; 2023; 18(11):e0291479. PubMed ID: 38011132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying gaps in HIV service delivery across the diagnosis-to-treatment cascade: findings from health facility surveys in six sub-Saharan countries.
    Church K; Machiyama K; Todd J; Njamwea B; Mwangome M; Hosegood V; Michel J; Oti S; Nyamukapa C; Crampin A; Amek N; Nakigozi G; Michael D; Gómez-Olivé FX; Nakiyingi-Miiro J; Zaba B; Wringe A
    J Int AIDS Soc; 2017 Jan; 20(1):21188. PubMed ID: 28364566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV Testing Disruptions and Service Adaptations During the COVID-19 Pandemic: A Systematic Literature Review.
    Mude W; Mwenyango H; Preston R; O'Mullan C; Vaughan G; Jones G
    AIDS Behav; 2024 Jan; 28(1):186-200. PubMed ID: 37548796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the Impact of the COVID-19 Pandemic on Accessing HIV Services in South Africa: A Systematic Review.
    Jardim CGR; Zamani R; Akrami M
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV.
    Gils T; Bossard C; Verdonck K; Owiti P; Casteels I; Mashako M; Van Cutsem G; Ellman T
    PLoS One; 2018; 13(1):e0191294. PubMed ID: 29351338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
    Ambia J; Renju J; Wringe A; Todd J; Geubbels E; Nakiyingi-Miiro J; Urassa M; Lutalo T; Crampin AC; Kwaro D; Kyobutungi C; Chimbindi N; Gomez-Olive FX; Tlhajoane M; Njamwea B; Zaba B; Mee P
    BMC Health Serv Res; 2017 Nov; 17(1):758. PubMed ID: 29162065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV Care Experiences During the COVID-19 Pandemic: Mixed-Methods Telephone Interviews with Clinic-Enrolled HIV-Infected Adults in Uganda.
    Linnemayr S; Jennings Mayo-Wilson L; Saya U; Wagner Z; MacCarthy S; Walukaga S; Nakubulwa S; Karamagi Y
    AIDS Behav; 2021 Jan; 25(1):28-39. PubMed ID: 32918641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to access to antiretroviral therapy by people living with HIV in an indonesian remote district during the COVID-19 pandemic: a qualitative study.
    Fauk NK; Gesesew HA; Seran AL; Ward PR
    BMC Infect Dis; 2023 May; 23(1):296. PubMed ID: 37147599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.
    Duda SN; Farr AM; Lindegren ML; Blevins M; Wester CW; Wools-Kaloustian K; Ekouevi DK; Egger M; Hemingway-Foday J; Cooper DA; Moore RD; McGowan CC; Nash D;
    J Int AIDS Soc; 2014; 17(1):19045. PubMed ID: 25516092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe.
    Chan AK; Ford D; Namata H; Muzambi M; Nkhata MJ; Abongomera G; Mambule I; South A; Revill P; Grundy C; Mabugu T; Chiwaula L; Cataldo F; Hakim J; Seeley J; Kityo C; Reid A; Katabira E; Sodhi S; Gilks CF; Gibb DM;
    BMC Health Serv Res; 2014 Aug; 14():352. PubMed ID: 25138583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of facility-level antiretroviral treatment patient status utilizing a national-level laboratory cohort: Toward an understanding of system-level tracking and clinic switching in South Africa.
    Murphy JP; Shumba K; Jamieson L; Nattey C; Pascoe S; Fox MP; Miot J; Maskew M
    Front Public Health; 2022; 10():959481. PubMed ID: 36590005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.
    Gedela K; Rajus N; Luis H; Fridayantara WD; Irwanto I; Sukmaningrum E; Wignall FS
    HIV Med; 2022 Oct; 23(9):1025-1030. PubMed ID: 35312145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020.
    Fisher KA; Patel SV; Mehta N; Stewart A; Medley A; Dokubo EK; Shang JD; Wright J; Rodas J; Balachandra S; Kitenge F; Mpingulu M; García MC; Bonilla L; Quaye S; Melchior M; Banchongphanith K; Phokhasawad K; Nkanaunena K; Maida A; Couto A; Mizela J; Ibrahim J; Charles OO; Malamba SS; Musoni C; Bolo A; Bunga S; Lolekha R; Kiatchanon W; Bhatia R; Nguyen C; Aberle-Grasse J;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):447-452. PubMed ID: 35324881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV care using differentiated service delivery during the COVID-19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs.
    McGinnis KA; Skanderson M; Justice AC; Akgün KM; Tate JP; King JT; Rentsch CT; Marconi VC; Hsieh E; Ruser C; Kidwai-Khan F; Yousefzadeh R; Erdos J; Park LS
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25810. PubMed ID: 34713585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modifications to ART service delivery models by health facilities in Uganda in promotion of intervention sustainability: a mixed methods study.
    Zakumumpa H; Bennett S; Ssengooba F
    Implement Sci; 2017 Apr; 12(1):45. PubMed ID: 28376834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of COVID-19 on HIV services and anticipated benefits of vaccination in restoring HIV services in Ethiopia: A qualitative assessment.
    Amhare AF; Zhao M; Seeley J; Zhang WH; Goyomsa GG; Geleta TA; Zhao R; Zhang L
    Front Public Health; 2022; 10():1033351. PubMed ID: 36408047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of service quality of public antiretroviral treatment (ART) clinics in South Africa: a cross-sectional study.
    Kinkel HF; Adelekan AM; Marcus TS; Wolvaardt G
    BMC Health Serv Res; 2012 Jul; 12():228. PubMed ID: 22849727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accessing Care During the COVID-19 Pandemic Using Telemedicine: Perspectives From People With HIV.
    Allison WE; Choi AN; Kawasaki K; Desai A; Melhado TV
    Health Promot Pract; 2023 Sep; 24(5):982-989. PubMed ID: 37440447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult HIV care resources, management practices and patient characteristics in the Phase 1 IeDEA Central Africa cohort.
    Divaris K; Newman J; Hemingway-Foday J; Akam W; Balimba A; Dusengamungu C; Kalenga L; Mbaya M; Molu BM; Mugisha V; Mukumbi H; Mushingantahe J; Nash D; Niyongabo T; Atibu J; Azinyue I; Kiumbu M; Woelk G
    J Int AIDS Soc; 2012 Nov; 15(2):17422. PubMed ID: 23199800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.